KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Return on Capital Employed (2019 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Return on Capital Employed for 7 consecutive years, with 0.14% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 22.0% to 0.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.14% through Dec 2025, up 22.0% year-over-year, with the annual reading at 0.13% for FY2025, 19.0% up from the prior year.
  • Return on Capital Employed hit 0.14% in Q4 2025 for Adaptive Biotechnologies, up from 0.19% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.14% in Q4 2025 to a low of 0.42% in Q2 2024.
  • Historically, Return on Capital Employed has averaged 0.29% across 5 years, with a median of 0.3% in 2025.
  • Biggest five-year swings in Return on Capital Employed: decreased -15bps in 2024 and later increased 22bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.25% in 2021, then decreased by -6bps to 0.26% in 2022, then crashed by -43bps to 0.38% in 2023, then rose by 5bps to 0.36% in 2024, then soared by 62bps to 0.14% in 2025.
  • Business Quant data shows Return on Capital Employed for ADPT at 0.14% in Q4 2025, 0.19% in Q3 2025, and 0.29% in Q2 2025.